SecBot SecBot
PRESS-RELEASE ·Filed Mar 25, 2026

OTLK

Outlook Therapeutics, Inc.
NEUTRAL
Impact 5/10
Horizonimmediate Processed7mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight • Neutral

Traders should monitor warrant exercise activity and cash burn rate, as the capital raise provides near-term liquidity but adds significant dilution risk if warrants are exercised. Given the small market cap ($16M), even partial warrant exercise could meaningfully impact share count.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.2100
T+0 close · Mar 25, 2026 · via day close
Latest settled
+709.52%
T+60 · $1.70
Vs SPY
+695.51%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 26 $0.2100entry
  2. T+1 · 8mo ago −0.95%α +0.75% · $0.2080
  3. T+5 · 8mo ago +4.29%α +2.62% · $0.2190
  4. T+20 · 7mo ago +50.00%α +39.33% · $0.3150
  5. T+60 · 5mo ago +709.52%α +695.51% · $1.70
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Outlook Therapeutics (OTLK) closed a public offering of 20 million shares and accompanying warrants to purchase 20 million shares at $0.25 per unit, raising $5.0 million in gross proceeds. The warrants are exercisable immediately at $0.25 per share and expire in five years, with potential for an additional $5.0 million in proceeds if fully exercised. Proceeds will be used for working capital and general corporate purposes.

Key Financial Metrics

Deal Value
$5.0M

Key Facts

  • Closed public offering of 20,000,000 shares and 20,000,000 warrants at $0.25 per unit
  • Aggregate gross proceeds of $5.0 million
  • Warrants exercisable immediately at $0.25 per share, five-year term
  • Potential additional $5.0 million in gross proceeds if warrants are fully exercised
  • Net proceeds to be used for working capital and general corporate purposes
  • H.C. Wainwright & Co. acted as exclusive placement agent
  • Offering made under effective shelf registration (Form S-3, filed March 2024)

Financial Impact

$5.0 million raised, with potential for another $5.0 million from warrant exercises

dilutioncashequity

Risk Factors

  • Significant equity dilution upon warrant exercise (20M additional shares possible)
  • Low share price ($0.25) increases sensitivity to market sentiment and liquidity risk
  • Proceeds may not be sufficient for long-term runway given biopharma development costs

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3262571

Track record

37 reports on OTLK

Performance horizon

13 of 23 bullish or bearish reports moved the stock their way by T+5. Best: +306.25% at T+20 after the May 26, 2026 report. 18 of 23 went positive at some point.

Filters
  1. Oct 13, 20264w ago SC 13G Neutral 4/10 Entry $0.5638 to $0.5200 Now $0.3960 −29.76% ▼ −7.77% −6.62% vs SPY
  2. Oct 6, 20265w ago Press Release Neutral 3/10 Entry $0.5720 to $0.5638 Now $0.3960 −30.77% ▼ −1.43% −1.29% vs SPY
  3. Sep 18, 20268w ago 8-K Neutral 3/10 Entry $0.6863 to $0.6211 Now $0.3960 −42.30% ▼ −9.50% −8.48% vs SPY
  4. Aug 14, 202613w ago 8-K Bearish 6/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
  5. Aug 14, 202613w ago 424B5 Bearish 7/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
  6. Aug 14, 202613w ago 8-K Bearish 6/10 No price data
  7. Aug 14, 202613w ago Press Release Mixed 7/10 Entry $0.7564 to $0.6472 Now $0.3960 −47.65% ▼ −14.44% −13.07% vs SPY
  8. Aug 12, 202613w ago Press Release Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
  9. Aug 12, 202613w ago 8-K Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
  10. Jul 24, 202616w ago 8-K Bullish 8/10 Entry $1.07 to $0.9766 Now $0.3960 −62.82% ▼ −8.30% −9.37% vs SPY
Showing 10 of 37

US Market Status

Market Closed · Opens in 6h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 25, 2026